Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era - A national study

American Heart Journal

Volumn 141, Issue 3, 2001, Pages 478-484

  Shotan, Avraham ^a   Gottlieb, Shmuel ^a   Goldbourt, Uri ^b   Boyko, Valentina ^a   Reicher Reiss, Henrietta ^a   Arad, Michael ^a   Mandelzweig, Lori ^a   Hod, Hanoch ^a   Kaplinsky, Elieser ^a   Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; NIFEDIPINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035094904     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.112998     Document Type: Article

References (30)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
3. ISIS 4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
4. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infraction
5. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction
6. Delays in thrombolytic therapy for acute myocardial infarction in Finland: Results of a national thrombolytic therapy delay study
7. The 60 minutes myocardial infarction project: Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction
8. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention project)
9. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction
10. Routine medical management of acute myocardial infarction: Lessons from overviews of recent randomized controlled trials
11. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
12. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion: Reperfusion in acute myocardial infarction
13. Did prognosis after acute infarction change during the past 30 years? A meta-analysis
14. Declining hospital mortality in acute myocardial infarction
15. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience, 1981 to 1991
16. Trends in acute myocardial infarction and coronary heart disease death in the United States
17. Thrombolysis for acute myocardial infarction: Why is there no extra benefit after hospital discharge?
18. Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials
19. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): A randomized intervention trial of nifedipine in patients with acute myocardial infarction
20. Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel
21. Improved survival of hospitalized patients with acute myocardial infarction from 1981-1983 to 1992 in Israel
22. Angiographic predictors of reocclusion after thrombolysis: Results from the Thrombolysis in Myocardial Infarction (TIMI)-4 trial
23. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
24. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: Prediction of clinical outcome
25. Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion: The Thrombosis and Angioplasty in Myocardial Infarction (Tacute myocardial infarction) study group
26. Prognosis of patients with a first non-Q wave myocardial infarction before and in the reperfusion era
27. Non-Q wave myocardial infarction: Recent changes in occurrence and prognosis: A community wide perspective